Afimkibart (PF06480605) is a humanised monoclonal antibody targeting TL1A (TNF-like Ligand 1A), which blocks TL1A-DR3 (death domain receptor 3) signalling on restrictive immune cells and fibroblasts. It can be used for inflammatory bowel disease and ulcerative colitis.
Purity:
99.20%
CAS Number:
[2911580-96-4]
Target:
TNF
* VAT and and shipping costs not included. Errors and price changes excepted
